Synovial Sarcoma — Trials

Synovial Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

94 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 33
Recruiting: 22
Ph III recruiting: 2
Growth YoY: —
Industry share: 33%
Top sponsor: USWM CT, LLC
Termination share: 45.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07174427	Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma	recruiting	Phase 3	5	Takara Bio Inc.INDUSTRY	1	Sep 28, 2026	clinicaltrials
NCT03016819	Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)(APROMISS)	recruiting	Phase 3	325	Advenchen Laboratories, LLCINDUSTRY	5	Feb 25, 2026